Skip to main content

Research Repository

Advanced Search

Heterochromatin modulation and PCG control of gene expression mediated by noncoding RNA in cancer

Rutland, Catrin S.; de Brot, Simone; James, Victoria; Mongan, Nigel P.

Authors

Simone de Brot

NIGEL MONGAN nigel.mongan@nottingham.ac.uk
Professor of Oncology



Contributors

Jayprokas Chakrabarti
Editor

Sanga Mitra
Editor

Abstract

In eukaryotes, the packaging of DNA and proteins, termed chromatin, is an essential determinant of transcription. The basic unit of chromatin, the nucleosome, is composed of ?146 base pairs of DNA spooled around a dense protein core containing two copies each of histones H2A, H2B, H3, and H4. These histone proteins are highly conserved and possess tails, which extend and interact with DNA. Covalent modifications that alter the charge of the histone tail are believed to influence their electrostatic interaction with DNA and act as interaction surfaces for epigenetic effectors that influence the level of chromatin compaction and accessibility to the transcriptional apparatus. Less-compacted chromosomal regions, euchromatin, tend to be gene rich and transcriptionally active. In contrast, condensed constitutive heterochromatin plays an essential function in chromosomal integrity and structural regions such as the centromere and telomere. Facultative heterochromatin plays an essential role by imposing the differentiation-specific transcriptional regulation required to underpin cellular identity. Long noncoding RNAs (lncRNAs) are emerging as key transcriptional regulators, which cooperate with the polycomb repressive complexes and the heterochromatin apparatus in differentiation. Unsurprisingly, disruption of this key pathway is now recognized to play important roles in carcinogenesis and metastases. In this chapter, we review current understanding of the normal and oncogenic functions of lncRNAs, polycomb, and heterochromatin.

Citation

Rutland, C. S., de Brot, S., James, V., & Mongan, N. P. (2018). Heterochromatin modulation and PCG control of gene expression mediated by noncoding RNA in cancer. In J. Chakrabarti, & S. Mitra (Eds.), Cancer and Noncoding RNAs, 359-372. Elsevier. doi:10.1016/b978-0-12-811022-5.00019-x

Acceptance Date Mar 15, 2017
Online Publication Date Oct 13, 2017
Publication Date Jul 18, 2018
Deposit Date Dec 7, 2018
Publisher Elsevier
Pages 359-372
Series Title Translational Epigenetics
Series Number 1
Book Title Cancer and Noncoding RNAs
Chapter Number 19
ISBN 9780128110225
DOI https://doi.org/10.1016/b978-0-12-811022-5.00019-x
Public URL https://nottingham-repository.worktribe.com/output/1387988
Publisher URL https://www.sciencedirect.com/science/article/pii/B978012811022500019X